2The Columbus investigators. Low molecular weight heparin in the treatment of patient with venous thromboembolism[J].N Engl J Med, 1997,337:657-662.
3Gurfinkel EP,Manos EJ,Mejail RI,et al.Low molecular weight heparin on aspirin in the treatment of unstable angina and silent ischemia[J].J Am Coll Cardiol,1995,26(2):313-318.
4Clinical Collaborative Study Group of Low Molecular Weight Heparin (Correspondent: HU Dayi, XU Juntang. Beijing Red Cross Chaoyang Hospital, Beijing University of Medical Sciences, Beijing 100020, China).不稳定性心绞痛、急性非Q波心肌梗死不同抗栓疗法的对比研究[J].中华心血管病杂志,2000,28(1):18-21. 被引量：172
6Alice J, Huddleston, Chad A, et al. Ebenroth.sildenafil for the treatment of pulmonary hypertension in pediatric pa- tients [J]. Pediatr Cardiol,2009 (7):871-882.
7Ozawa H,Abiko Y,Akimoto T. A 50-year history of new drugs in Japan-the development and progress of anti-di- abetic drugs and the epidemiological aspects of diabetes mellitus [J]. Yakushigaku Zasshi, 2003,38 ( 1 ) : 11-27.
8Balci Akpinar R,Celebioglu A.Effect of injection duration on bruising associated w ith subcutaneous heparin:a quasi-experimental w ithin-subject design[J].Int J Nurs Stud,2008,45(6):812-817.
